Veradermics shares surge as hair loss drug trial meets primary endpoint
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
In phase 2/3 clinical trials targeting male pattern baldness, the oral sustained-release minoxidil preparation VDPHL01 achieved all primary and key secondary endpoints with extremely high statistical significance. Read more
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
U.S. stocks open higher, Nasdaq rises 64 points at the open
AiCoin•2026/05/18 13:33
US Stock Market Opens with Broad-based Gains, Intel Up 5.3%
BlockBeats•2026/05/18 13:32
Report: Novo Nordisk shows highlights under price pressure
格隆汇•2026/05/18 13:28
Citi: Quantum computing breakthroughs are accelerating, Bitcoin faces significant quantum risks
Chaincatcher•2026/05/18 13:18
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$77,170.04
-1.36%
Ethereum
ETH
$2,139.19
-2.34%
Tether USDt
USDT
$0.9995
-0.00%
BNB
BNB
$640.89
-1.90%
XRP
XRP
$1.39
-2.03%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$85.04
-1.62%
TRON
TRX
$0.3579
+0.48%
Dogecoin
DOGE
$0.1057
-4.92%
Hyperliquid
HYPE
$45.89
+7.34%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now